Imbalance of Pulmonary Microvascular Endothelial Cell-Expression of Metalloproteinases and Their Endogenous Inhibitors Promotes Septic Barrier Dysfunction
Open Access
- 26 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (9) , 7875
Abstract
Sepsis is a life-threatening disease characterized by excessive inflammation leading to organ dysfunction. During sepsis, pulmonary microvascular endothelial cells (PMVEC) lose barrier function associated with inter-PMVEC junction disruption. Matrix metalloproteinases (MMP) and a disintegrin and metalloproteinases (ADAM), which are regulated by tissue inhibitors of metalloproteinases (TIMPs), can cleave cell–cell junctional proteins, suggesting a role in PMVEC barrier dysfunction. We hypothesize that septic PMVEC barrier dysfunction is due to a disruption in the balance between PMVEC-specific metalloproteinases and TIMPs leading to increased metalloproteinase activity. The effects of sepsis on TIMPs and metalloproteinases were assessed ex vivo in PMVEC from healthy (sham) and septic (cecal ligation and perforation) mice, as well as in vitro in isolated PMVEC stimulated with cytomix, lipopolysaccharide (LPS), and cytomix + LPS vs. PBS. PMVEC had high basal Timp expression and lower metalloproteinase expression, and septic stimulation shifted expression in favour of metalloproteinases. Septic stimulation increased MMP13 and ADAM17 activity associated with a loss of inter-PMVEC junctional proteins and barrier dysfunction, which was rescued by treatment with metalloproteinase inhibitors. Collectively, our studies support a role for metalloproteinase–TIMP imbalance in septic PMVEC barrier dysfunction, and suggest that inhibition of specific metalloproteinases may be a therapeutic avenue for septic patients.Keywords
Funding Information
- Ontario Thoracic Society (G-17-0018385, 149038)
- Lawson Health Research Institute Internal Research Fund (G-17-0018385, 149038)
- Heart & Stroke Foundation of Ontario/Canada (G-17-0018385, 149038)
- Canadian Institutes of Health Research (G-17-0018385, 149038)
This publication has 62 references indexed in Scilit:
- Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNFEMBO Molecular Medicine, 2013
- Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharideEMBO Molecular Medicine, 2012
- Tissue inhibitors of metalloproteinasesGenome Biology, 2011
- Increased Neovascularization in Mice Lacking Tissue Inhibitor of Metalloproteinases-3Investigative Ophthalmology & Visual Science, 2011
- Acute Lung Injury: Epidemiology, Pathogenesis, and TreatmentJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsisCritical Care, 2009
- The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological ImplicationsDevelopmental Cell, 2009
- The role of adherens junctions and VE-cadherin in the control of vascular permeabilityJournal of Cell Science, 2008
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004